Brussels, 18/07/2014 (Agence Europe) - A genetically modified ovum that cannot become a human being is not defined as an embryo and therefore can be patented, argued a European Court of Justice Advocate General on Thursday 17 July in an opinion on case C-364/13.
The British legal system had sent a case to the European Court of Justice about a biotech company, International Stem Cell Corporation (ISC), which has lodged two patent requests with the British Intellectual Property Office on...